Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.581 EUR | -0.09% | +1.93% | -18.04% |
13/05 | Earnings Flash (CARA) CARA THERAPEUTICS Posts Q1 Revenue $2.1M, vs. Street Est of $1.7M | MT |
13/05 | Cara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 6.92M 6.41M 578M | Sales 2025 * | 6.3M 5.83M 526M | Capitalization | 35.11M 32.51M 2.93B |
---|---|---|---|---|---|
Net income 2024 * | -68M -62.96M -5.68B | Net income 2025 * | -64M -59.26M -5.34B | EV / Sales 2024 * | 8.18 x |
Net Debt 2024 * | 21.5M 19.91M 1.8B | Net Debt 2025 * | 78.9M 73.06M 6.59B | EV / Sales 2025 * | 18.1 x |
P/E ratio 2024 * |
-0.54
x | P/E ratio 2025 * |
-0.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.58% |
Latest transcript on Cara Therapeutics, Inc.
1 week | +1.93% | ||
Current month | -1.69% | ||
1 month | -20.78% | ||
3 months | -35.39% | ||
6 months | -41.79% | ||
Current year | -18.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 06/18/06 | |
Ryan Maynard
DFI | Director of Finance/CFO | 54 | 12/22/12 |
Scott Terrillion
CMP | Compliance Officer | 61 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Vogelbaum
CHM | Chairman | 60 | 01/10/01 |
Jeffrey Ives
BRD | Director/Board Member | 73 | 16/14/16 |
Helen Boudreau
BRD | Director/Board Member | 58 | 02/23/02 |
Date | Price | Change |
---|---|---|
07/24/07 | 0.581 | -0.09% |
06/24/06 | 0.5815 | -6.59% |
05/24/05 | 0.6225 | +0.97% |
04/24/04 | 0.6165 | +4.49% |
03/24/03 | 0.59 | -0.25% |
Real-time BOERSE MUENCHEN, June 08, 2024 at 01:13 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.82% | 93.19B | |
-1.32% | 39.62B | |
-12.88% | 33.78B | |
+64.77% | 26.82B | |
-16.31% | 15.35B | |
-5.78% | 13.13B | |
-11.38% | 11.6B | |
-49.84% | 10.26B | |
+5.24% | 9.43B |
- Stock Market
- Equities
- CARA Stock
- 69C Stock